"持久的左心室辅助装置作为在旧世界和新世界移植的桥梁"
相关实验视频
Updated: Apr 6, 2026

16:11
Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
35.3K
Andrea Fernandez Valledor1, Gal Rubinstein1, Cathrine M Moeller1
1Division of Cardiology, Advanced Cardiac Care, Columbia University Irving Medical Center, New York, New York.
概括
左心室辅助器件 (LVAD) 对等待移植的末期心力衰竭患者至关重要. 在LVAD用于桥梁到移植指示的全球差异凸显了改善获取政策调整的必要性.
科学领域:
- 心脏病学 心脏病学
- 移植医学 移植医学
- 医疗器械 医疗器械
背景情况:
- 心脏移植是最终阶段心力衰竭的主要治疗方法.
- 有限的捐赠器官需要替代策略,如左心室辅助装置 (LVADs).
- 对于被选中的患者来说,LVAD是重要的桥梁到移植 (BTT) 选择.
研究的目的:
- 为了比较心脏移植和美国和欧洲的LVAD使用情况.
- 分析器官供应和分配政策对LVAD BTT实践的影响.
- 为了确定对公平的LVAD接入的潜在政策修改.
主要方法:
- 对心脏移植和LVAD使用数据的比较综述.
- 分析美国和欧洲的器官分配政策.
- 检查患者选择,植入前优化和移植后结果.
主要成果:
- 欧洲显示LVAD对BTT的使用越来越多,而美国的利率在2018年政策变化后下降.
- 由于器官的可用性,政策和财务因素,在LVAD使用方面存在显著的全球差异.
- 美国政策变化影响了LVAD BTT数字,需要进行潜在的修订.
结论:
- 在等待移植的心力衰竭患者的管理中,LVAD是必不可少的.
- 美国的政策修改,考虑到支持持续时间和并发症等因素,可能会提高LVAD植入率.
- 解决全球差距对于公平获得拯救生命的心脏支持至关重要.
相关概念视频
Heart Failure VI: Adjunct Therapies
588
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
588
Cardiomyopathy II: Dilated Cardiomyopathy
776
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
776
Cardiomyopathy V: Interprofessional Care
664
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
664

